VAM
ZSAN

Visium Asset Management’s Zosano Pharma Corporation ZSAN Stock Holding History

Visium Asset Management’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-593
Closed -$1.64M – 907
2015
Q3 		$1.64M Sell
593
-14
-2% -$78.6K 0.02% 461
2015
Q2 		$3.08M Sell
607
-36
-6% -$223K 0.04% 366
2015
Q1 		$4.55M Buy
+643
New +$4.82M 0.07% 277

Other funds holding ZSAN

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Visium Asset Management's ZSAN Position: Q4 2015 in Review

Visium Asset Management sold out of Zosano Pharma Corporation (ZSAN) in Q4 2015, closing a stake of 593 shares — an estimated $1.64M sold.

Visium Asset Management first reported a position in ZSAN in Q1 2015 and held it in 3 quarters. The position peaked at $4.55M in Q1 2015. 13 funds tracked by Wall St. Rank hold ZSAN as of Q4 2015.

  • Visium Asset Management reported no remaining Zosano Pharma Corporation position as of Q4 2015 after selling out during the quarter.
  • Visium Asset Management sold 593 Zosano Pharma Corporation shares in Q4 2015, an estimated $1.64M.
  • Visium Asset Management first reported a position in Zosano Pharma Corporation in Q1 2015 and held it in 3 quarters.
  • Visium Asset Management's Zosano Pharma Corporation position peaked at $4.55M in Q1 2015.
  • 13 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q4 2015.

Based on Visium Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.